Filing Details
- Accession Number:
- 0000899243-20-004913
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-18 17:02:46
- Reporting Period:
- 2020-02-14
- Accepted Time:
- 2020-02-18 17:02:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1346302 | Xeris Pharmaceuticals Inc | XERS | Pharmaceutical Preparations (2834) | 203352427 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652410 | Beth Hecht | C/O Xeris Pharmaceuticals, Inc. 180 N. Lasalle Street, Suite 1600 Chicago IL 60601 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-14 | 4,000 | $4.15 | 8,083 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents shares purchased in an underwritten public offering of the Issuer at the public offering price of $4.15 per share.
Billionaire Hedge Funds
